Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2014-005331-14-ES
EUCTR2014-005331-14-ES
Active, not recruiting
Not Applicable

A prospective randomized trial to analyze the effect of the gonadotropin administered during controlled ovarian stimulation on embryo kinetics of development - Type of gonadotropin and embryo kinetics of development

IVI Madrid0 sitesMarch 11, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsElonvaPuregonMenopur

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
IVI Madrid
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2015
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
IVI Madrid

Eligibility Criteria

Inclusion Criteria

  • •Women \<38 years old
  • •Weight \<60 kg
  • •Own oocytes
  • •Patients have to provide signed informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 200
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Oocyte donors
  • •Vitrified oocytes
  • •Severe male factor (\<1 million spz/ml)
  • •Weight \>60 kg

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Impact of lung protective ventilatory strategy on systemic and pulmonary inflammatory responses during laparoscopic surgery: is it really helpful?Inflammatory stress in patients undergoing laparoscopic gynaecological surgeryAnaesthesiology - Other anaesthesiology
ACTRN12614000978662Afyon Kocatepe University40
Completed
Not Applicable
Is it useful to continue administration of gonadotropin releasing hormone (GnRH) agonist after embryo transfer?Infertility treated by ICSIPregnancy and ChildbirthIn vitro fertilization
ISRCTN13123887The Egyptian IVF Center (Egypt)446
Active, not recruiting
Phase 1
Comparison of the effect of autologous cell therapy with repeated angioplasty and assessment of the effect of combination of both methods on peripheral arterial disease in diabetic patientsIn our study, the effect of autologous cell therapy (ACT) will be compared with repeated percutaneous transluminal angioplasty (re-PTA) in patients with diabetic foot and then will be compared the effect of combination treatment of ACT and re-PTA against re-PTA itself. We suppose an enhanced effect of this combination on on macro- and microcirculation. Expected results of the project include improved tissue oxygenation, enhanced DF healing and a reduced risk of major amputation.MedDRA version: 19.0Level: PTClassification code 10062585Term: Peripheral arterial occlusive diseaseSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2016-001398-34-CZInstitut klinické a experimentální medicíny60
Completed
Not Applicable
Evaluation of bodyoil fortified with iron, folic acid, vitamin B12 and vitamin D for infant massage
CTRI/2017/11/010710Grand Challenges Canada444
Active, not recruiting
Not Applicable
Randomized Evaluation of the effectiveness in terms of reduction of cerebral ischemia in patients undergoing carotid angioplasty load of different doses of clopidogrel (300vs600mg) and high-dose atorvastati
EUCTR2011-005330-18-ITIVERSITA' CAMPUS BIOMEDICO150